Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who are willing to give informed consent to participate in the study. 2. Patients diagnosed with Type 2 Diabetes Mellitus within a period of 24 weeks, as per ADA Diagnostic Criteria of Type 2 Diabetes Mellitus
Exclusion criteria
Exclusion criteria: 1. Patients who are not willing to give consent to participate in the study or to undergo DEXA, Bioelectrical Impedance, or blood Investigatons. 2. Patients with duration of Type 2 Diabetes Mellitus more than 24 weeks. 3. Patients taking drug therapy like Insulin, SGLT 2 Inhibitors and Sulphonylureas.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visceral fat mass(g), volume (cm3), area(cm2) via DEXA scanTimepoint: at baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Visceral fat rating via Bioelectrical Impedance, values of Biomarkers (Adiponectin, Chemerin, hsCRP), Anthropometry (Waist Circumference, Hip Circumference, Waist to Hip ratio, BMI)Timepoint: at baseline | — |
Countries
India
Contacts
PGIMER